Donanemab [TRAILBLAZER]

On the day that this Randomised Controlled Trial was published in The Journal of the American Medical Association, 17 July 2023, headlines and news coverage TRAILBLAZED across the world [well ahead of regulatory scrutiny]:

This slideshow requires JavaScript.

On Radio 4 the following report was given [please click here or on image below to play audio]:

The full paper can be read below. Tables and Figures appear at the end [please click on any image to enlarge]:

   

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.